FibroGen
FGEN
FGEN
187 hedge funds and large institutions have $2.38B invested in FibroGen in 2017 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 68 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
8% less capital invested
Capital invested by funds: $2.58B → $2.38B (-$200M)
10% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 68
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
187
Holding in Top 10
4
Calls
$21.9M
Puts
$23.5M
Top Buyers
| 1 | +$33.6M | |
| 2 | +$30.7M | |
| 3 | +$28.7M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$26.4M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$14.8M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$11.8M | |
| 3 | -$9.76M | |
| 4 |
BA
Boston Advisors
Boston,
Massachusetts
|
-$8.94M |
| 5 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$8.71M |